Watch the full Hunter’s Moon rise this weekend before 4 back-to-back ‘supermoons’ head our wayOctober 24, 2026
General Nearly one third of patients with advanced melanoma saw tumors disappear completely after receiving TIL therapy plus pembrolizumab immunotherapyBy Healthcare Propulsion StaffOctober 24, 20260 Results from a clinical trial have revealed nearly one third (29.2 percent) of patients with advanced melanoma saw their tumors…
General Recurrent brain tumors undergo unique genetic changes after treatmentBy Healthcare Propulsion StaffOctober 14, 20260 When patients are diagnosed with certain brain tumors, one of the biggest unanswered questions is what happens when the cancer…
